Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · derivative · entry 7 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2021-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
SaleCommon Stock | 20,200 | $51.06 | $1,031,412.00 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · nonDerivative · entry 6 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,521 Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionCommon Stock | 9,005 | $19.60 | $176,498.00 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · nonDerivative · entry 5 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionCommon Stock | 16,666 | $13.87 | $231,157.42 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · nonDerivative · entry 4 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionCommon Stock | 13,333 | $9.22 | $122,930.26 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · nonDerivative · entry 3 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionCommon Stock | 20,000 | $7.27 | $145,400.00 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · nonDerivative · entry 2 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 01:51 UTC |
Weiss Lawrence MartinChief Medical Officer
|
Exercise / conversionCommon Stock | 50,000 | $6.98 | $349,000.00 |
DisclosureSEC source: 0001077183-20-000227 · wf-form4_160808347590230.xml · nonDerivative · entry 1 Weiss Lawrence Martin · CIK 0001761625 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 22:57 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000223 · wf-form4_160772744474977.xml · derivative · entry 4 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 15,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 22:57 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 15,000 | $49.99 | $749,850.00 |
DisclosureSEC source: 0001077183-20-000223 · wf-form4_160772744474977.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 Read SEC document |
| December 11, 2020 Filed Dec 11, 2020 22:57 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 15,000 | $8.03 | $120,450.00 |
DisclosureSEC source: 0001077183-20-000223 · wf-form4_160772744474977.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:49 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 25,000 | $50.52 | $1,263,000.00 |
DisclosureSEC source: 0001077183-20-000225 · wf-form4_160798614957845.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,025,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:49 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 20,000 | $50.30 | $1,006,000.00 |
DisclosureSEC source: 0001077183-20-000225 · wf-form4_160798614957845.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,050,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 07, 2020 Filed Dec 7, 2020 23:23 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 45,658 | $49.45 | $2,257,788.10 |
DisclosureSEC source: 0001077183-20-000221 · wf-form4_160738336847250.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,070,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:23 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 64,394 | $48.07 | $3,095,419.58 |
DisclosureSEC source: 0001077183-20-000221 · wf-form4_160738336847250.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,115,658 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:19 UTC |
Johnson Kevin CDirector
|
SaleCommon Stock | 24,683 | $47.88 | $1,181,822.04 |
DisclosureSEC source: 0001077183-20-000219 · wf-form4_160738316657613.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,983 Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:23 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 19,948 | $48.03 | $958,102.44 |
DisclosureSEC source: 0001077183-20-000221 · wf-form4_160738336847250.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,180,052 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 23:03 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000217 · wf-form4_160712294905089.xml · derivative · entry 3 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,370 Underlying: Common Stock · 8,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 23:03 UTC |
Bonello WilliamPresident, Informatics
|
SaleCommon Stock | 8,000 | $46.80 | $374,400.00 |
DisclosureSEC source: 0001077183-20-000217 · wf-form4_160712294905089.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,060 Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 23:03 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionCommon Stock | 8,000 | $8.03 | $64,240.00 |
DisclosureSEC source: 0001077183-20-000217 · wf-form4_160712294905089.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 23:04 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 77,074 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000215 · wf-form4_160634543123462.xml · derivative · entry 7 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 77,074 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 23:04 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 77,074 | $45.48 | $3,505,325.52 |
DisclosureSEC source: 0001077183-20-000215 · wf-form4_160634543123462.xml · nonDerivative · entry 5 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,902 Read SEC document |
| November 25, 2020 Filed Nov 25, 2020 23:04 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionCommon Stock | 77,074 | $7.52 | $579,596.48 |
DisclosureSEC source: 0001077183-20-000215 · wf-form4_160634543123462.xml · nonDerivative · entry 4 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 23:04 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 72,926 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000215 · wf-form4_160634543123462.xml · derivative · entry 6 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,074 Underlying: Common Stock · 72,926 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 23:04 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 52,926 | $45.19 | $2,391,725.94 |
DisclosureSEC source: 0001077183-20-000215 · wf-form4_160634543123462.xml · nonDerivative · entry 3 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,902 Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 23:04 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionCommon Stock | 72,926 | $7.52 | $548,403.52 |
DisclosureSEC source: 0001077183-20-000215 · wf-form4_160634543123462.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · derivative · entry 10 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
SaleCommon Stock | 100,000 | $42.34 | $4,234,000.00 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · nonDerivative · entry 7 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,422,790 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 20,000 | $7.52 | $150,400.00 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · nonDerivative · entry 6 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,522,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 23:53 UTC |
HIPP RAYMOND RDirector
|
SaleCommon Stock | 70,000 | $42.28 | $2,959,600.00 |
DisclosureSEC source: 0001077183-20-000213 · wf-form4_160574356403275.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,800 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 358,752 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · derivative · entry 9 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 358,752 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
SaleCommon Stock | 118,752 | $41.56 | $4,935,333.12 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · nonDerivative · entry 5 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,502,790 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 358,752 | $7.52 | $2,697,815.04 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · nonDerivative · entry 4 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,621,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 121,248 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · derivative · entry 8 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,752 Underlying: Common Stock · 121,248 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
SaleCommon Stock | 121,248 | $42.18 | $5,114,240.64 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · nonDerivative · entry 3 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,262,790 Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 01:30 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 121,248 | $7.52 | $911,784.96 |
DisclosureSEC source: 0001077183-20-000211 · wf-form4_160557663745672.xml · nonDerivative · entry 2 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,384,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:00 UTC |
Pedulla Denise EGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $7.85 | $0.00 |
DisclosureSEC source: 0001077183-20-000209 · wf-form4_160522200451410.xml · derivative · entry 3 Pedulla Denise E · CIK 0001804602 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vested ratably over the first four anniversary dates of the grant date. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:00 UTC |
Pedulla Denise EGeneral Counsel
|
SaleCommon Stock | 2,262 | $42.00 | $95,004.00 |
DisclosureSEC source: 0001077183-20-000209 · wf-form4_160522200451410.xml · nonDerivative · entry 2 Pedulla Denise E · CIK 0001804602 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,726 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 23:00 UTC |
Pedulla Denise EGeneral Counsel
|
Exercise / conversionCommon Stock | 15,000 | $7.85 | $117,750.00 |
DisclosureSEC source: 0001077183-20-000209 · wf-form4_160522200451410.xml · nonDerivative · entry 1 Pedulla Denise E · CIK 0001804602 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 22:25 UTC |
JONES STEVEN CDirector
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 8 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,932 Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 22:25 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 81,000 | $36.55 | $2,960,550.00 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,932 Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 22:25 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 141,049 | $36.95 | $5,211,760.55 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,200,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 22:25 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 19,000 | $36.56 | $694,640.00 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,932 Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 22:25 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 38,951 | $36.34 | $1,415,479.34 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,341,049 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 24, 2020 Filed Sep 25, 2020 01:02 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,333 | $0.00 Strike: $9.11 | $0.00 |
DisclosureSEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · derivative · entry 4 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2021-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On July 28, 2016, Mr. Crowther was granted 8,333 stock options. The options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| September 24, 2020 Filed Sep 25, 2020 01:02 UTC |
CROWTHER BRUCE KDirector
|
SaleCommon Stock | 8,333 | $35.01 | $291,738.33 |
DisclosureSEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · nonDerivative · entry 3 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,483 Read SEC document |
| September 24, 2020 Filed Sep 25, 2020 01:02 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionCommon Stock | 8,333 | $9.11 | $75,913.63 |
DisclosureSEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · nonDerivative · entry 2 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2020 Filed Sep 25, 2020 01:02 UTC |
CROWTHER BRUCE KDirector
|
SaleCommon Stock | 2,400 | $35.68 | $85,632.00 |
DisclosureSEC source: 0001077183-20-000187 · wf-form4_160099571411498.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,483 Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 22:16 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 37,991 | $37.13 | $1,410,605.83 |
DisclosureSEC source: 0001077183-20-000185 · wf-form4_159977617760663.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,380,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 22:16 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 71,583 | $36.98 | $2,647,139.34 |
DisclosureSEC source: 0001077183-20-000185 · wf-form4_159977617760663.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,417,991 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 22:16 UTC |
JONES STEVEN CDirector
|
SaleCommon Stock | 10,426 | $36.13 | $376,691.38 |
DisclosureSEC source: 0001077183-20-000185 · wf-form4_159977617760663.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,489,574 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.